Pharmafile Logo
Pharmafocus logo
Advanced Search

Aragen appoints Aniel Khubchandani as CEO of development and manufacturing solutions division

August 8, 2025
Manufacturing Services, Manufacturing and Production Aragen Life Sciences, CEO, Corporate, development and manufacturing solutions, manufacturing services

Aragen Life Sciences, based in Hyderabad, India, has appointed Aniel Khubchandani as CEO of its development and manufacturing solutions (DMS) …

Appointment
drug-trials

Faron reports increased remission rate in trial for myelodysplastic syndrome candidate

August 7, 2025
Medical Communications, Research and Development Faron Pharmaceuticals, Oncology, US Food and Drug Administration, acute myeloid leukemia, myelodysplastic syndrome

Faron Pharmaceuticals has reported a rise in complete remission (CR) rates among patients with frontline high-risk myelodysplastic syndrome (HR-MDS) in …

News
hospital

Sanome’s AI tool gains certification for early detection of hospital infections

August 7, 2025
Business Services, Research and Development AI, Devices, Infections and infestations, Medicines and Healthcare products Regulatory Agency, NHS, Sanome, hospital-acquired infections

Sanome’s MEMORI, an artificial intelligence (AI) medical device that can predict hospital-acquired infections up to 72 hours before they present, …

News
computer_doctor

Cognizant launches tool to support secure AI integration in healthcare platforms

August 7, 2025
Business Services, Technical Consultancy Cognizant, Devices, healthcare software

US tech solutions company, Cognizant, has launched TriZetto AI Gateway, a new tool designed to embed generative AI functions across …

News

PLL Therapeutics to present ALS research strategy at Bioshares Biotech Summit

August 7, 2025
Medical Communications, Research and Development Bioshares Biotech Summit, Neurology, PLL Therapeutics, amyotrophic lateral sclerosis, neurodegenerative diseases

French biotech, PLL Therapeutics, will present its approach to early detection and treatment of Amyotrophic Lateral Sclerosis (ALS) at the …

News

MedaSystems appoints Anton White as vice president of growth

August 6, 2025
Business Services Corporate, MedaSystems, vice president of growth

US software solutions company, MedaSystems, has named Anton White as vice president of growth to lead global go-to-market strategy and …

Appointment
lungs

M42 study highlights positive performance of AI model for tuberculosis screening

August 6, 2025
Research and Development AI, Infections and infestations, M42, X-ray, tuberculosis

Healthcare tech company, M42, has published results from one of the largest real-world studies of an artificial intelligence (AI)-powered tuberculosis …

News
sanofi

Sanofi completes acquisition of Vigil Neuroscience to early neurology pipeline

August 6, 2025
Mergers and Acquisitions Alzheimer's disease, Corporate, Neurology, Sanofi, Vigil Neuroscience, neurodegenerative diseases

Sanofi has announced that it has finalised its acquisition of Vigil Neuroscience, a US-based biotechnology company specialising in neurodegenerative diseases. …

News
brain-770044_960_720

Lilly’s drug for early Alzheimer’s shows promising results

August 6, 2025
Medical Communications, Research and Development Alzheimer's, Eli Lilly, Neurology, dementia

Eli Lilly (Lilly) has announced positive new data from the long-term extension of its phase 3 study, showing that Kisunla …

News
blood-1813410_960_720

FDA grants orphan drug designation to relapsed or refractory multiple myeloma candidate

August 6, 2025
Medical Communications, Research and Development Oncology, Sanofi, US Food and Drug Administration, myeloma

The US Food and Drug Administration (FDA) has granted orphan drug designation to SAR446523, Sanofi’s investigational monoclonal antibody developed for …

News

Polpharma Biologics and Fresenius Kabi partner to develop treatment for ulcerative colitis and Crohn’s disease

August 5, 2025
Mergers and Acquisitions Corporate, Crohn’s disease, Fresenius Kabi, Gastrointestinal tract, Polpharma Biologics, ulcerative colitis

Polpharma Biologics has signed a global licensing agreement with Fresenius Kabi for the commercialisation of PB016, a proposed biosimilar to …

News

Freya Pharma launches phase 2 study of therapy for female sexual dysfunction

August 5, 2025
Research and Development Female Sexual Interest/Arousal Disorder (FSIAD), Freya Pharma Solutions, Genito-Urinary system, sexual health

Freya Pharma Solutions has announced the initiation of a phase 2 study evaluating its Lybrido to treat female sexual interest/arousal …

News

Advarra appoints Brian Hart as chief technology officer

August 5, 2025
Business Services, Technical Consultancy Advarra, Corporate, chief technology officer, digital solutions

Digital solutions company, Advarra, has named Brian Hart as chief technology officer, strengthening its leadership team. Hart brings more than …

Appointment

Hansa Biopharma announces positive data for Duchenne muscular dystrophy gene therapy

August 4, 2025
Research and Development Duchenne Muscular Dystophy, Hansa Biopharma, Rare Diseases, Sarepta Therapeutics, clinical trial, genetic disorder

Hansa Biopharma has announced encouraging results from its ongoing SRP-9001-104 trial, which is investigating the use of imlifidase as a …

News
office-space-1988480_960_720

Biocair expands globally with new Shanghai office

August 4, 2025
Logistics & Distribution, Manufacturing and Production Biocair, Corporate, life sciences logistics

Life science logistics specialist, Biocair, has announced the opening of a new office in Shanghai, marking a significant expansion of …

News
nerve-cell-2213009_960_720

Central nervous system cancer metastases – the evolution of diagnostics and treatment

August 4, 2025
CERo therapeutics, Cancer, T cell, immunotherapy

The current forms of immunotherapy, how T cell therapy works and what the future holds

Feature

Five Facts about sleep and mental health

August 3, 2025
Medical Communications Five Facts, Psychiatry, insomnia, mental health, sleep, sleep disorders, sleep health

1 Rapid Eye Movement (REM) sleep enhances creative thinking and helps the brain form connections between ideas, supporting mental wellbeing …

Feature

The Pharma Files: With Priyanka Hinton from CHASE

August 3, 2025
Business Services, Recruitment CHASE, The Pharma Files

Pharmafile chats with Priyanka Hinton, Customer Solutions Director at Chase People about the best parts of her job and her …

Feature

A challenge we can no longer ignore: meeting the needs of people with Crohn’s Disease in the UK

August 3, 2025
Research and Development Crohn’s disease, Immunology, Lilly UK, autoimmune disease, immunology

By Holly Thomas, Associate Vice-President Specialty Care at Lilly UK and Ireland Immunology care in the UK is at a …

Feature

Ryvu Therapeutics publishes research revealing potential drug combination for colorectal cancer

August 1, 2025
Medical Communications, Research and Development Oncology, Ryvu Therapeutics, colorectal cancer

Ryvu Therapeutics has published new findings from its ONCO Prime target discovery platform in Scientific Reports. The study reveals a …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026